Heron Therapeutics | HRTX - 市值

金融业

USD

USD 255.88M

现金及等价物

USD 43.07M

USD 11.12M

USD 238.07M

USD 96.1M

USD 149.65M

股息收益率

0

USD 38K

USD -3.88M

126

EPS每股收益

USD -0.02

股本和储备

USD 13.28M

USD 29.47M

债务利息支出

USD 600K

USD 433K

USD 140.64M

USD 183.4M

USD -2.95M

USD 40.55M

USD 38K

普通股股本

USD 188.31M

USD -2.95M

USD 40.59M

销售和管理费用

USD 23.74M

USD 54.57M

贸易债权人

USD 8.99M

应收帐款人

USD 89.59M

	市值	更改		日
ALKERMES	USD 5.53B		909M	2026-05
Alnylam Pharmaceuticals	USD 44.15B		8.39B	2026-03
Amarin	USD 290M		51M	2025-12
ANI Pharmaceuticals	USD 1.77B		269M	2025-12
Anika Therapeutics	USD 139M		3M	2025-12
Arrowhead Research	USD 9.02B		4.25B	2025-12
Eisai	JPY 1.31T		140.95B	2025-12
Emergent BioSolutions	USD 125M		51M	2023-12
Esperion Therapeutics	USD 885M		351M	2025-12
GlaxoSmithKline	GBP 83.8B		9.44B	2026-03
Heron Therapeutics	USD 238M		7M	2025-12
Insmed	USD 37.12B		6.68B	2025-12
Merck	USD 297.1B		35.84B	2026-03
Nektar Therapeutics	USD 15.62B		14.76B	2026-05
Neurocrine Biosciences	USD 13.34B		800M	2026-05
Pacira	USD 915M		149M	2026-03
Regeneron Pharmaceuticals	USD 81.68B		560M	2026-03
Roche Holding	CHF 266.34B		55.46B	2025-12
Ultragenyx Pharmaceutical	USD 2.04B		176M	2026-05
Veracyte	USD 2.62B		704M	2026-05
Vertex Pharmaceuticals	USD 111.03B		2.55B	2026-05